Pham, James P.
Joshua, Anthony M.
da Silva, Ines P.
Dummer, Reinhard
Goldinger, Simone M.
Funding for this research was provided by:
University of Zurich
Article History
Accepted: 4 January 2023
First Online: 29 March 2023
Declarations
:
: Ines P. da Silva had travel support by BMS and MSD and speaker fee by Roche, BMS and MSD. Reinhard Dummer has intermittent, project-focused consulting and/or advisory relationships with Novartis, Merck Sharp & Dohme (MSD), Bristol-Myers Squibb (BMS), Roche, Amgen, Takeda, Pierre Fabre, Sun Pharma, Sanofi, Catalym, Second Genome, Regeneron, Alligator, T3 Pharma, MaxiVAX SA, Pfizer and touchIME outside the submitted work. James P. Pham, Anthony M. Joshua and Simone M. Goldinger declare no competing interests.